FGFR3 and breast cancer: For instance, activating mutations of fibroblast growth factor receptor 3 (FGFR3) occur in 45-75% of human BC; those of PI3K and RAF in ~25% and ~8% of human BC, respectively; and those inactivating PTEN in ~8% of human BC [1, 2].